Consolidated Balance Sheets Statement - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash and cash equivalents	$ 18,461	$ 23,350
Accounts receivable, net of allowance for doubtful accounts of $3,746 and $3,397 at 2015 and 2014, respectively	152,448	197,163
Inventories	44,462	43,371
Prepaid expenses	11,013	14,246
Income taxes receivable	5,852	10,980
Other current assets	9,987	12,710
TOTAL CURRENT ASSETS	242,223	301,820
PROPERTY, PLANT AND EQUIPMENT, net	146,965	149,014
INTANGIBLES, net	13,523	10,642
GOODWILL	178,159	164,464
DEFERRED TAX ASSETS, net	10,087	3,876
OTHER ASSETS	44,148	45,837
TOTAL ASSETS	635,105	675,653
CURRENT LIABILITIES:
Accounts payable	40,539	47,084
Accrued payroll and related costs	33,016	34,617
Taxes other than payroll and income	9,225	11,199
Unearned revenue	13,918	11,009
Income taxes payable	7,217	8,333
Other current liabilities	20,148	19,624
TOTAL CURRENT LIABILITIES	124,063	131,866
LONG-TERM DEBT	428,000	356,000
DEFERRED COMPENSATION	42,809	42,705
DEFERRED TAX LIABILITIES, net	2,505	7,210
OTHER LONG-TERM LIABILITIES	$ 43,643	$ 43,879
COMMITMENTS AND CONTINGENCIES (Note 6)
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	$ 0	$ 0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 44,350,002 issued and 42,407,281 outstanding at 2015 and 45,600,002 issued and 43,636,984 outstanding at 2014	1,142	1,174
Additional paid-in capital	269	0
Retained earnings	236,041	415,906
Accumulated other comprehensive income (loss)	(11,901)	(11,894)
Treasury shares (at cost), 1,942,721 at 2015 and 1,963,018 at 2014	(237,795)	(317,613)
Total Core Laboratories N.V. shareholders' equity (deficit)	(12,244)	87,573
Non-controlling interest	6,329	6,420
TOTAL EQUITY (DEFICIT)	(5,915)	93,993
TOTAL LIABILITIES AND EQUITY	$ 635,105	$ 675,653